Mesenchymale Stammzellen bei Arthritis

Standard

Mesenchymale Stammzellen bei Arthritis. / David, J-P; Zwerina, J; Schett, G.

In: Z RHEUMATOL, Vol. 68, No. 3, 01.05.2009, p. 228-33.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearch

Harvard

David, J-P, Zwerina, J & Schett, G 2009, 'Mesenchymale Stammzellen bei Arthritis', Z RHEUMATOL, vol. 68, no. 3, pp. 228-33. https://doi.org/10.1007/s00393-008-0395-1

APA

David, J-P., Zwerina, J., & Schett, G. (2009). Mesenchymale Stammzellen bei Arthritis. Z RHEUMATOL, 68(3), 228-33. https://doi.org/10.1007/s00393-008-0395-1

Vancouver

David J-P, Zwerina J, Schett G. Mesenchymale Stammzellen bei Arthritis. Z RHEUMATOL. 2009 May 1;68(3):228-33. https://doi.org/10.1007/s00393-008-0395-1

Bibtex

@article{99802f6868664866ab2c80ea39d32f0a,
title = "Mesenchymale Stammzellen bei Arthritis",
abstract = "While one of the major achievements of the 20th century was prolonging life expectancy in developed countries, the main challenge of the 21st century is to improve the quality of life of the aging population. Aging is associated with a progressive reduction of organ system function. Therefore, regenerative medicine will be one of the major developing fields of medicine. This new medical field does not only apply to aging but also to all degenerative diseases, such as arthritis and degenerative joint disease, which lead to progressive degeneration of mesenchymal tissues such as bone and cartilage. The discovery of pluripotent mesenchymal stem cells (MSCs) offers a promising alternative to surgery for non-invasive regenerative therapies of mesenchymal tissues. This review focuses on the characterization and potential application of MSCs in the regeneration of damaged joints.",
keywords = "Animals, Arthritis, Rheumatoid, Cell Differentiation, Chondrocytes, Humans, Mesenchymal Stem Cell Transplantation, Osteoarthritis, Regeneration, Tissue Scaffolds",
author = "J-P David and J Zwerina and G Schett",
year = "2009",
month = may,
day = "1",
doi = "10.1007/s00393-008-0395-1",
language = "Deutsch",
volume = "68",
pages = "228--33",
journal = "Z RHEUMATOL",
issn = "0340-1855",
publisher = "D. Steinkopff-Verlag",
number = "3",

}

RIS

TY - JOUR

T1 - Mesenchymale Stammzellen bei Arthritis

AU - David, J-P

AU - Zwerina, J

AU - Schett, G

PY - 2009/5/1

Y1 - 2009/5/1

N2 - While one of the major achievements of the 20th century was prolonging life expectancy in developed countries, the main challenge of the 21st century is to improve the quality of life of the aging population. Aging is associated with a progressive reduction of organ system function. Therefore, regenerative medicine will be one of the major developing fields of medicine. This new medical field does not only apply to aging but also to all degenerative diseases, such as arthritis and degenerative joint disease, which lead to progressive degeneration of mesenchymal tissues such as bone and cartilage. The discovery of pluripotent mesenchymal stem cells (MSCs) offers a promising alternative to surgery for non-invasive regenerative therapies of mesenchymal tissues. This review focuses on the characterization and potential application of MSCs in the regeneration of damaged joints.

AB - While one of the major achievements of the 20th century was prolonging life expectancy in developed countries, the main challenge of the 21st century is to improve the quality of life of the aging population. Aging is associated with a progressive reduction of organ system function. Therefore, regenerative medicine will be one of the major developing fields of medicine. This new medical field does not only apply to aging but also to all degenerative diseases, such as arthritis and degenerative joint disease, which lead to progressive degeneration of mesenchymal tissues such as bone and cartilage. The discovery of pluripotent mesenchymal stem cells (MSCs) offers a promising alternative to surgery for non-invasive regenerative therapies of mesenchymal tissues. This review focuses on the characterization and potential application of MSCs in the regeneration of damaged joints.

KW - Animals

KW - Arthritis, Rheumatoid

KW - Cell Differentiation

KW - Chondrocytes

KW - Humans

KW - Mesenchymal Stem Cell Transplantation

KW - Osteoarthritis

KW - Regeneration

KW - Tissue Scaffolds

U2 - 10.1007/s00393-008-0395-1

DO - 10.1007/s00393-008-0395-1

M3 - SCORING: Zeitschriftenaufsatz

C2 - 19384551

VL - 68

SP - 228

EP - 233

JO - Z RHEUMATOL

JF - Z RHEUMATOL

SN - 0340-1855

IS - 3

ER -